News Agency
The Times

Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

  • Written by PR Newswire

NEW YORK, June 29, 2023 /PRNewswire/ -- Cresilon, Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for Cresilon Hemostatic Gel™ ("CHG™").

This marks Cresilon's...

Read more: Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology

How Does Temporary Fencing Help Simplify Project Planning?

Why Does Temporary Fencing Matter During Project Planning?  A controlled boundary is essential when construction, infrastructure maintenance, demolition,  landscaping, and other projects are underway. That is when temporary fencing becomes an important  option to consider. The fencing layout affects more than site... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion